COPD/Asthma/ILD (8/27-9/4) Flashcards

1
Q

What part of the airway is the most susceptible to significant airflow obstruction?

A

Bronchioles - not supported by cartilage - lack submucosal glands - contain circumferential smooth muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What type of lung defect is COPD?

A

obstructive (air intake is limited)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What two diseases fall under COPD?

A

chronic bronchitis emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the main symptoms of COPD?

A

dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bronchitis has what type of lung defect?

A

obstructive (air intake is limited)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the pathogenesis of/causes bronchitis?

A

1) hypertrophy of the mucus-secreting glands in the bronchi leads to:
a) hypersecretion -> mucus plugging
b) thickening of the bronchial wall

2) (recurrent) infections due to altered epithelium, cilia, and mucus production (inadequate clearance) -> inflammation/formation of lymphoid follicles
3) intermittent bronchospasms of smooth muscle surrounding airways

all impedes air flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are pathological findings of bronchitis? (4)

A

1) inflammatory cells (macrophage, neutrophils) and lymphoid follicles
2) thickening of bronchiole wall due to hypertrophy of mucus glands (reid index >50%)
3) luminal mucus plugging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is chronic bronchitis diagnosed?

A

productive cough >3 months for 2 consecutive years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some general characteristics of emphysema in terms of: type of defect? histological finding? elastic recoil? compliance? fibrosis?

A
  • obstructive lung defect
  • permanent enlargement of airspaces distal to the terminal bronchioles + destruction of alveolar walls/decrease in airway tethering
  • loss of elastic recoil
  • increased compliance
  • NO FIBROSIS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 2 main patterns of emphysema? Where are they located? What are they caused by?

A

1) centriacinar - focal destruction of respiratory bronchioles due to cigarette smoking 2) panacinar - destruction of alveoli distal to the terminal bronchioles due to A1AT deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the role of A1AT? How does it protect against smoke?

A

Alpha-1-antitrypsin - blocks elastase Smoke recruits inflammatory cells, which increase elastase production to destroy lung parenchyma, thus reducing elastic recoil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does smoking cause emphysema?

A

Smoke does 2 things: 1) it recruits inflammatory cells, which increase elastase production to destroy lung parenchyma, thus reducing elastic recoil. 2) it inactivates A1AT, which causes results in increased elastase activity, thus resulting in an increased lung parenchyma destruction and ultimately reduction of elastic recoil.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What type of lung defect is asthma?

A

obstructive defect (air can’t get in)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is asthma?

A

hyper-responsiveness of the tracheobronchial tree to stimuli, which leads to repeated episodes of reversible bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the two main types of Asthma?

A

EXtrinsic

  • allergic/Type I hypersensitivity
  • atopy/genetic predisposition to producing IgE to allergens
  • may be due to increased Th2 production, which secrete IL’s to stimulate B cells to produce IgE and activate eosinophils to produce major basic protein.

INtrinsic
- non-allergic - non-hereditary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which T cell is a key player in the extrinsic pathway of asthma?

A

Th2 - secrete IL’s to stimulate B cells to produce IgE, which stimulates mast cells - activate eosinophils to produce major basic protein both result in damage to the epithelium and airway constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the pathological findings of asthma? 93)

A

1) thick mucus plugs
2) thickened epithelial basement membranes
3) eosinophils
4) inflammation
5) edema
6) hypertrophied smooth muscle + submucosal gland proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is bronchiectasis?

A

permanent airway DILATION due to the sequelae of continued airway damage (repeat infections, aspirations of drugs and chemicals, obstruction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the pathology of bronchiectasis?

A

loss of cilia increased mucus destruction of alveolar wall due to inflammation w. or w.o microabscesses, squamous metaplasia, peribronchial fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What inflammatory cells predominate in COPD lungs?

A

macrophages, CD8, and neutrophils, which promote inflammation that ultimately lead to small airway narrowing and alveolar destruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the difference betwen reversible and irreversible airflow limitation in COPD lungs?

A

Reversible: airway inflammation + airway remodeling

Irreversible: parenchymal destruction, loss of elastic recoil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are 5 mechanisms of airflow obstruction?

A
  1. mucus hypersecretion -> luminal obstruction
  2. disruputed alveolar attachments -> easier for airway to collapse (ie emphysema)
  3. mucosal inflammation/fibrosis -> thickened alveolar walls (ie bronchitis)
  4. reduced elastic recoil -> reduced airflow (emphysema)
  5. smooth muscle contraction -> narrowing of the airways (ie bronchitis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How are the symptoms of chronic bronchitis different than that of emphysema, even though they both fall under the umbrella term of COPD?

A

Chronic bronchitis:

1) productive cough
2) hypoxemia
3) pulmonary HTN

Emphysema

1) breathlessness
2) adequate oxygen saturation
3) cachexia (wasting disease - loss of weight, muscle atrophy, fatigue, weakness)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the elastase hypothesis?

A

A1AT is a major inhibitor of serine proteases in the lungs, and it antagonizes the effects of the neutrophils in the lungs.

Deficiency is caused by a recessive mutation, where the liver (site of A1AT production) does not synthesize it or release it.

Thus, a smoker with A1AT deficiency is at high risk of developing COPD at an earlier age (30-50) compared to the usual onset (50-60)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

In what diseases would you see a decreased FEV1/FVC ratio? (3)

What is the name of this type of defect?

A

COPD

asthma

Cystic fibrosis

aka _O_BSTRUCTIVE DEFECT - can’t get air _O_ut

26
Q

Predict and compare what you would see for emphysema vs chronic bronchitis in terms of:

FRC
RV
FVC
TLC
DLCO
FEV1/FVC ratio

A

Emphysema
FRC - increase due to elastic recoil (less inward force, more outward force of the thorax)
RV - increase due to air trapping/loss of elastic recoil
FVC - decrease due to air trapping
TLC - increase
DLCO - decrease due to neutrophil-mediated alveolar destruction
FEV1/FVC ratio - decrease, since it’s an obstructive defect

Chronic Bronchitis
FRC - normal because only the conducting zones of the airway are altered
RV - increase due to air trapping since patient is unable to exhale all of the air completely due to thickened walls and phlegm
FVC - decrease or normal due to air trapping
TLC - normal because elastic recoil is NOT affected
DLCO - normal, since the respiratory zones (site of gas exchange) is not affected
FEV1/FVC ratio - decrease, since it’s an obstructive defect

27
Q

What are 3 types of bronchodilators? What is their mode of action?

A

1) b-agonists: albuterol, salmeterol, formoterol
2) anti-cholinergics: block muscarinic reeptors that release ACh (normally bronchoconstrictors): ipratropium and tiotropium
3) methylxanthines: phosphodiesterase inhibitor (increases cAMP bioavailability) - theophylline

All serve to increase cAMP, which causes smooth muscle relaxation

28
Q

Why are glucocorticosteroids used for treatments with COPD?

A

anti-inflammatory

inhaled - for patients with COPD and FEV1 <50% of predicted + frequent exacerbations

oral - long-term treatment not recommended due to site effects

29
Q

What is the # 1 therapy for patients with COPD/emphysema?

A

STOP SMOKING. shiz.

30
Q

What are the 4 characteristic symptoms of asthma?

What are some of the physical findings of asthma?

A

Clinical symptoms:

  1. dyspnea
  2. cough
  3. wheeze
  4. chest tightness

symptoms are worse at night.

Physical findings:

  1. expiratory wheezes
  2. hyperresponsance
  3. diminshed breath sounds
  4. use of accessory muscles to breath
  5. CXR: hyperinflation of the lungs

NOTE: physical exam may be normal if the patient isn’t undergoing an attack

31
Q

What is the most important risk factor for asthma?

A

atopy - a genetic predisposition to forming IgE and Th2 phenotypes

32
Q

What are the 4 clinical manifestations of asthma?

A
  1. airway inflammation (narrow, reddened, edematous)
  2. enhanced bronchial responsiveness -> bronchoconstriction
  3. reversible airway obstruction
  4. excess mucus secretion
    5.
33
Q

What is the gross pathological features of asthma? microscopic features?

A

Gross:

  1. narrowed, reddened, and edematous airways

Microscopic:

  1. inflammation - eosinophils, Th2, mast cells
  2. thickened basement membrane due to collagen deposition
  3. decreased attachment to airway walls
  4. increased epithelial cells (hyperplasia) lining the lumen
  5. hypertrophied smooth muscle
  6. mucus plugging
  7. airway edema (exudative)
  8. vascular congestion
34
Q

T/F Asthma pathology is observed throughout lung parenchyma

A

False. It is only observed in the conducting airways and does NOT extend into the lung parenchyma

35
Q

Asthma is characterized by acute inflammation, chronic inflammation, and remodeling. What is the difference between these three stages?

A

Acute: altered airway pathophysiology - hyperresponsiveness, mucus production, and bronchoconstriction (all leads to airflow obstruction

Chronic: increased airway dsfunction due to epithelial cell damage

Remodeling: permanently injured/altered lung function due to hyperplasia

36
Q

Would you expect to find exudate or transudate in asthmatic lungs?

A

Exudate - extravascular fluid with high protein content due to vessel obstruction during inflammation

37
Q

What is the expected spirometry results of a patient with Asthma?

A

decreased FEV1 (due to obstructive airflow limitation)

decreased FEV1/FVC ratio

38
Q

What is the pathogenesis of asthma?

A

allergens that trigger acute or chronic responses:

acute: mast cell and IgE mediated bronchoconstriction
chronic: eosinophil-mediated inflammation

39
Q

What are some viral causes of asthma?

A

RSV - triggers a Th2 response; infections early in life have been linked to asthma development

Rhinovirus ** most common cause of acute episodes of wheezing

40
Q

How does exercise trigger asthmatic attacks?

A

hyperventilation increases osmolality of fluid in the airway, which leads to mast cell degranulation

41
Q

What are the 3 diagnostic tools used to diagnose asthma?

A
  1. spirometry
  2. methacholine test - delivers various concentrations to induce bronchoconstriction and measures FEV1
  3. exhaled NO test

Note that CXR is not a useful diagnostic tool for asthma

42
Q

What is the difference between rescue therapy and controller therapy for asthma treatment? What are some examples of each?

A
  • *rescue**: quick relief fo bronchoconstriction and associated symptoms
  • b2 agonist (albuterol)
  • antichoinergics (ipratropium)
  • corticosteroids
  • *controller therapy**: long-term management/antiinflammatory medication
  • **cortiosteroids
  • b-agonists
  • anti-leukotrienes
  • immunomodulators
  • allergen immunotherapy
  • mast-cell stabilizers
  • theophylline**
43
Q

What is ILD?

A

interstitial lung disease - diffuse parenchymal lung disease that is affected by interstitial inflammation and/or fibrosis

44
Q

ILD is broken down into 3 major branches:

  1. Granulomatous
  2. Non-granulomatous (idiopathic)
  3. Known cause

What are some examples of each?

A
  • *Granulomatous**
  • Sarcoidosis
  • hypersensitivity pneumonitis
  • *Non-granulomatous (idiopathic)**
  • Usual interstitial pneumonitis, UIP (Idiotpathic pulmonary fibrosis)
  • Non-UIP
  • *Known cause**
  • ARDs
  • Pneumoconiosis (coal miners, silicosis, asbestosis)
  • Collagen dz
  • SLE/RA
  • Drugs
45
Q

What is the biological processes that lead to iLD?

What is the INITIAL step of ILD? What is the END-STAGE step of ILD?

A

inhaled substance/immune host response causes INTERSTITIAL DAMAGE, which activates type II neumocytes, causes alveolar capillaries and epithelial cells, and macrophages.

  • Type II pneumocytes become reactive and stick out from the interstitium
  • Alveolar capillaries become leaky, which allows fibroblasts + fibrin + inflammatory cells to enter the interstitum and organize granulation tissue
    • fibroblasts organizes fibrin into granulation tissue AND produce collagen, which ultimately leads to fibrosis
  • macrophages recruits inflammatory cells and engulfs debris.

all of these ultimately leads to honeycomb lungs, which is the end-stage fibrosis

Initial: alveolitis

End stage: honeycomb lungs

46
Q

What is granulation tissue?

A

healing/reparative tissue response

47
Q

What is ARDs?

What causes ARDs?

What cell types are affected in ARDs? (this will also help you answer the next question)

What is the pathophysiology of ARDs?

What is the histolocal appearance of ARDs?

How does it resolve?

A

Acute respiratory distress

caused by acute lung injury due to:

1) trauma
2) sepsis
3) infections
4) gastric aspiration

cells affected:
1) alveolar capillary/endothelial cells → edematous fluid + inflammatory cells in interstitum
NOTE: edematous fluid mixes with cellular debris to form a hyaline membrane
2) type I pneumocytes get damaged and die → altered surfactant production
3) type II is also damaged, but the remaining cells try to repopulate the damaged alveoli.

  • *Pathophysiology**: formation of the hyaline membrane results in a thickened diffusion barrier, which does two things:
    1) lack of oxygen diffusion → hypoxemia and cyanosis
    2) makes the surface more “sticky”, which increases the surface tension and consequently increases the

Histological appearance:

1) edema in interstitial space
2) hyaline membrane (when edematous fluid mixes with cellular debris in the alveolar septum)

  • *early: typical diffuse alveolar damage (DAD)
    late: organization into fibrous tissue OR complete resolution**
48
Q

What is pneumoconiosis?

What are examples of pneumoconiosis?

A

Pneumoconiosis - ILD caused by inhalation of dust, characterized by inflammation, coughing, and fibrosis; many are related to occupational exposures

Examples:
coal minors lungs
silicosis
asbestosis

49
Q

What is coal minors pneumoconiosis?

What are the 2 phases of the disease?

A

ILD that results in progressive fibrosis
due to coal dust +/- silica inhalation

Early phase: presence of

  • anthracosis - carbon-laden macrophage
  • macules - aggregates of carbon-laden macrophages
  • nodules - macules + fibrosis

Complex phase: coalescence of nodules, leads to progressive massive fibrossi (mostly silica-induced)

50
Q

What is silicosis pneumoconiosis?

There are two types of silica (crystalline/quartz and amorphous silica), which one is more dangerous?

What are the 2 phases of the disease?

A

ILD due to silica inhalation

Crystalline/quartz is most fibrogenic and is harder to get rid of; impairs macrophage form

Early: fibrotic nodules with collagen core (usually in upper lobe)

Complex: coalescence into hard scars, esp. in the lungs + lymph nodes

51
Q

What is asbestosis pneumoconiosis?

There are two types of abestos (serpentine and amphibole), which one is more dangerous?

What is the histological features of asbestosis pneumoconiosis?

A

ILD due to inhalation of crystalline-hydrated silica (asbestos), causes diffuse interstitial fibrosis

amphibole is the more pathogenic form

histological feature: long asbestos fibers present as iron coated bodies within macrophages.

52
Q

What is hypersensitivity Pneumonitis?

What type of hypersensitivity dominates the early stages? later stages?

What type of lung pathology would you expect to see?

A

ILD - granulomatous type

it is an ** immune response** to inhaled organic dust, mold, occupational antigens.

early stages: Type III - immune complex
later stages: Type IV - delayed hypersensitivity

Pathology: granulomatous inflammation, thickened interstitium, late stage fibrosis + honeycomb lungs

53
Q

What is sarcoidosis?

What type of lung pathology would you expect to see?

A

ILD - granulomatous type

it is a T-CELL mediated immune response to inhaled an unknown antigen.

Pathology:

  • *- bilateral hilar lymphadenopathy**
  • *- granulomatous inflammation** that may ultimately fuse to form non-nucleated giant cells
  • *- fibrosis**

Treatment:

  • asymptomatic patients: no treatment
  • severe symptoms: corticosteroids
54
Q

What are the two major symptoms of ILD? What is the underlying causes of these two major symptoms?

What are the physical findings in a patient with ILD?

A

dyspnea

  1. decreased lung compliance (stiffer) - lungs need to generate a greater inspiratory pressure to inflate the lungs
  2. increased physiological dead-space - need to increase ventilation to maintain a nomral PCO2

coughing

  1. stimulation of vagal afferent pathways + receptors in the airways

Physical findings:

  1. crackles (rales)
  2. clubbing in distal phalynx
55
Q

What is idiopathic pulmonary fibrosis?

What type of lung pathology would you expect to see?

What is unique about IPF compared to all of the other ILD’s?

A

IPF is an ILD of uknown etiology, but the pathology is the typical ILD pathology (interstitial thickening + honeycomb lung).

note that IPF can occur independently of inflammation, ie there is excess pro-fibrotic growth factors and cytokines that promote fibrosis, rather than inflammation (as in the case with hypersensitivity pneumonitis)

56
Q

What is the expected PFT values for a patient with ILD?

TLC
FRC
RV
VC
FEV1/FVC ratio
flow rates

A

TLC, FRC, RV, and VC will decrease - there is LESS compliance in ILD lungs and therefore the inspiratory muscles can’t overcome the elastic recoil of the lungs and can only inflate the lung to a lower volume

FEV1/FVC ratio will INCREASE since this is a RESTRICTIVE disease

Flow rate: decreased due to decreased TLC, but since the elastic recoil is increased (as a result of decreased compliance) the flow rate wil be higher at a given lung volume in an ILD patient compared to normal.

57
Q

Comment on the lung function of a patient with ILD in terms of:

compliance
diffusion
VQ mismatch
exercise

A
  • compliance - decreased due to inflammation/collagen deposition
  • diffusion - decreased due to thickened alveolar-capillary interface/loss of surface area
  • VQ mismatch - increased due to less compliant areas that receive less ventilation + thickened septums increase equilibration time
  • exercise - induces O2 desaturation even with mdoest activities; mostly due to VQ mismatch
58
Q

What is the breathing pattern for a patient with ILD? Differentiate between when the person is asleep vs when they’re awake.

A

Awake: patient has rapid shallow breathing to miminize discomfort associated with dyspnea.

Asleep: no real difference in breathing pattern between normal and ILD patient since the patient is unaware of the dyspnea.

59
Q

What is the prognosis for a patient with ILD?

A

Shit hits the fan. It’s bad. Mean survival time: 3years at the time of diagnosis.

60
Q

What are some of the diseases caused by inspired substances?

A
  • *pneumoconiosis** - chronic inhalation of inorganic dust that leads to parenchymal inflammation and fibrosis
  • *asthma** - inhalation of inorganic dust exposure that causes acute symptoms
  • *hypersensitivity pneumonitis** - inhalation of organic particles (ie malt worker’s lungs caused by Aspergillus fumigatus)
  • *occupational asthma** - inhalation of organic particles (ie grains)
61
Q

Smoking: what type of physiological responses does smoking cause?

A

Smoking contains nicotine, which binds to ACh receptors at autonomic ganglia, thereby

  • increase HR, BP, CO
  • increase catecholamine release + ACTH release from adrenal medulla
  • increase relaxation at the NMJ (due to persistant activation-inactivation of the NM receptors)
  • promotes mental stimulation, relaxtion, learning, memory, and attention
  • promotes thrombosis, platelet aggregation, and vasospasms
62
Q

What are 3 pharmacological agents used for smoking cessation?

A

Nicotine (patches)

bupropion (Zyban)

varenicline (chantix)